Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0L6QN
|
||||
Former ID |
DNC011480
|
||||
Drug Name |
LOFENTANIL
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [533543] | ||
Structure |
Download2D MOL |
||||
Formula |
C27H34N2O7
|
||||
Canonical SMILES |
CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2C)CCC3=CC=CC=C3)C(=O)OC
|
||||
InChI |
1S/C25H32N2O3/c1-4-23(28)27(22-13-9-6-10-14-22)25(24(29)30-3)16-18-26(19-20(25)2)17-15-21-11-7-5-8-12-21/h5-14,20H,4,15-19H2,1-3H3
|
||||
InChIKey |
IMYHGORQCPYVBZ-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 61380-40-3
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Mu-type opioid receptor | Target Info | Inhibitor | [533543] | |
Kappa-type opioid receptor | Target Info | Inhibitor | [533543] | ||
Delta-type opioid receptor | Target Info | Inhibitor | [533543] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Enkephalin releaseP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Opioid prodynorphin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Enkephalin release | |||||
Opioid proenkephalin pathway | |||||
Opioid proopiomelanocortin pathway | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.